The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · IEX Real-Time Price · USD
27.14
+0.24 (0.89%)
At close: Jul 19, 2024, 4:00 PM
27.24
+0.10 (0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

The Pennant Group Revenue

The Pennant Group had revenue of $575.34M in the twelve months ending March 31, 2024, with 18.43% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $156.92M with 24.08% year-over-year growth. In the year 2023, The Pennant Group had annual revenue of $544.89M with 15.14% growth.

Revenue (ttm)
$575.34M
Revenue Growth
+18.43%
P/S Ratio
1.42
Revenue / Employee
$99,351
Employees
5,791
Market Cap
815.44M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023544.89M71.65M15.14%
Dec 31, 2022473.24M33.55M7.63%
Dec 31, 2021439.69M48.74M12.47%
Dec 31, 2020390.95M52.42M15.49%
Dec 31, 2019338.53M52.47M18.34%
Dec 31, 2018286.06M35.07M13.97%
Dec 31, 2017250.99M33.77M15.54%
Dec 31, 2016217.23M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Clover Health Investments 1.85B
InnovAge Holding 741.33M
Cytek Biosciences 200.79M
Atrion 176.67M
Standard BioTools 126.76M
CureVac 64.13M
Mesoblast 7.25M
Revenue Rankings